Project Grant K01DA065810
Award Date 5/1/26
Completion Date 4/30/31
Dollars Obligated $195K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Austin, TX 78705, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $742,500 Project Grant (R34) to Massachusetts General Hospital on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This three-year pilot study, concluding June 30, 2028, will develop and test a peer recovery coaching intervention designed to promote tobacco abstinence in individuals with concurrent opioid use disorder and tobacco use disorder (MOUD-TUD). The project will adapt an...
- Federal Grant Award Summary The University of Connecticut Health Center received a $191,700 Project Grant (K99/R00 Award) from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), effective February 15, 2026 through January 31, 2028. This award supports research into the mechanisms of action (MOA) of peer recovery support (PRS) services for individuals receiving treatment for opioid use disorder (OUD). The research aims to address the ongoing...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a $159,615 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 15, 2025, for research extending through June 30, 2027. This K99/R00 award supports a research initiative titled "Predicting Craving and Relapse Using Neurobehavioral Markers of Goals and Habits in Opioid Use Disorder." The project delivers longitudinal neurobehavioral...
- FEDERAL PROJECT GRANT AWARD SUMMARY The National Institute on Drug Abuse (NIDA) awarded a $490,179 Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) to the University of Texas at Austin on May 15, 2026, for research investigating the neurobiological mechanisms mediating fentanyl-induced elevations in risk-taking behavior in rats. The five-year project, concluding February 28, 2031, addresses a critical knowledge gap regarding how synthetic opioids impair decision-making and...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Texas at Austin a $651,468 Project Grant on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop, evaluate, and disseminate StatWiseAI, an artificial intelligence-powered educational tool designed to enhance methodological rigor in large-scale data analysis. The three-year project, with completion targeted for August 31, 2028, addresses the critical...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Weill Medical College of Cornell University a $1,740,756 Project Grant on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a mixed-methods study examining the impact of peer support services (PSS) on treatment engagement and adverse events for Medicaid beneficiaries with substance use disorder. The project, which extends through July 31, 2030, will rigorously evaluate...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under its Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $249,000 Project Grant to the University of Texas at Austin effective August 1, 2025, through July 31, 2028. This Pathway to Independence Award supports postdoctoral research led by Dr. Ayland Letsinger under the mentorship of Drs. Jerrel Yakel and Guohong Cui at the National Institute of Environmental Health Sciences. The research investigates...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $144,252 to the University of Massachusetts Medical School, effective September 1, 2025, through August 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This award supports a mentoring-focused research initiative led by Dr. Carreiro to develop digital biomarker-driven solutions for opioid use disorder (OUD) prevention and treatment while simultaneously building...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Texas Medical Branch at Galveston a $795,090 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, with a completion date of May 31, 2030. This award supports discovery and development of small molecule ligand probes targeting GPR52 (G protein-coupled receptor 52) as a novel therapeutic approach for cocaine use disorder (CUD). The research...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a $193,751 Career Development Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) to the Trustees of Boston University, effective May 1, 2026 through April 30, 2031, to support research advancing the quality of care for Medicaid enrollees in outpatient substance use disorder (SUD) treatment facilities. The award funds the development of an independent researcher in SUD services through a rigorous...